Current Neuropharmacology : Impact Factor & More
eISSN: 1875-6190pISSN: 1570-159X
Share this on:
Key Metrics
CiteScore 
11.7
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
2.3
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Current Neuropharmacology
Current Neuropharmacology Journal Specifications
| Overview | |
| Publisher | BENTHAM SCIENCE PUBL LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2003 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Current Neuropharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Current Neuropharmacology
Global Research Trends of Protein Post-translational Modifications in Alzheimer's Disease: A Bibliometric Analysis.
- 26 Jul 2026
- Current neuropharmacology
The MID1IP1/S100A10-mGluR5 Axis in Seizures: Immune-Metabolic Crosstalk and Enhanced Therapeutic Efficacy of Benfotiamine/Phenytoin Combination.
- 26 Jul 2026
- Current neuropharmacology
PP2A: Decoding Its Structure, Regulation and Therapeutic Applications in Neurological Disorders.
- 25 Jul 2026
- Current neuropharmacology
PCSK9 Inhibitors for Secondary Prevention in Patients with Prior Stroke: A PRISMA-Guided Systematic Review.
- 25 Jul 2026
- Current neuropharmacology
Mechanisms and Applications of Transcranial Ultrasound Stimulation in Neurological Disorders and Psychiatric Conditions.
- 24 Jul 2026
- Current neuropharmacology
Targeting Ferroptosis-associated Histone Acylation for Amelioration of Neurological Disease.
- 24 Jul 2026
- Current neuropharmacology
Global Research Trends of Protein Post-translational Modifications in Alzheimer's Disease: A Bibliometric Analysis.
- 26 Jul 2026
- Current neuropharmacology
The MID1IP1/S100A10-mGluR5 Axis in Seizures: Immune-Metabolic Crosstalk and Enhanced Therapeutic Efficacy of Benfotiamine/Phenytoin Combination.
- 26 Jul 2026
- Current neuropharmacology
PP2A: Decoding Its Structure, Regulation and Therapeutic Applications in Neurological Disorders.
- 25 Jul 2026
- Current neuropharmacology
PCSK9 Inhibitors for Secondary Prevention in Patients with Prior Stroke: A PRISMA-Guided Systematic Review.
- 25 Jul 2026
- Current neuropharmacology
Mechanisms and Applications of Transcranial Ultrasound Stimulation in Neurological Disorders and Psychiatric Conditions.
- 24 Jul 2026
- Current neuropharmacology
Targeting Ferroptosis-associated Histone Acylation for Amelioration of Neurological Disease.
- 24 Jul 2026
- Current neuropharmacology
FAQs on Current Neuropharmacology
How long has Current Neuropharmacology been actively publishing? 
What is the publishing frequency of Current Neuropharmacology?
How many articles did Current Neuropharmacology publish last year?
What is the eISSN & pISSN for Current Neuropharmacology?
What is Citescore for Current Neuropharmacology?
What is SNIP score for Current Neuropharmacology?
What is the SJR for Current Neuropharmacology?
Who is the publisher of Current Neuropharmacology?
